𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opportunities and hurdles in the treatment of BRCA1-related breast cancer

✍ Scribed by Drost, R; Jonkers, J


Book ID
120991943
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
650 KB
Volume
33
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


BRCA1-related breast cancer in Austrian
✍ Teresa M. U. Wagner; Regine A. MΓΆslinger; Daniela Muhr; Gudrun Langbauer; Kora H πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 76 KB πŸ‘ 2 views

We identified 17 BRCA1 mutations in 86 Austrian breast and ovarian cancer families (20%) that were screened for mutations by denaturing high-performance liquid chromatography (DHPLC) and the protein truncation test (PTT). Eleven distinct mutations were detected, 4 of them (962del4, 2795del4, 3135del

Clinico–pathological characteristics of
✍ Pierre O. Chappuis; Victoria Nethercot; William D. Foulkes πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 2 views

Approximately 2% to 5% of all breast cancers are hereditary, meaning that the cancer predisposition is carried as a monogenic trait. Several highly penetrant breast cancer predisposing genes have been identified. These discoveries will permit a refined description of breast cancer occurring as part

Massive parallel amplicon sequencing of
✍ Kim De Leeneer; Jan Hellemans; Joachim De Schrijver; Machteld Baetens; Bruce Pop πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 584 KB

This study describes how the new massive parallel sequencing technology can be implemented in a diagnostic setting for the breast cancer susceptibility genes (BRCA1 and BRCA2). The throughput was maximized by increasing uniformity in coverage, obtained by a multiplex approach, which outperformed poo